Profile of patients with Inflammatory Bowel Disease at the Gastroenterology Outpatient Clinic of the Federal University of Pelotas

Gabriela Breitenbach dos Santos, Daniela Nogueira Zambrano, Luis Antonio Benvegnú, Elza Cristina Miranda da Cunha


Aim: To establish the profile of patients with inflammatory bowel disease treated at the Gastroenterology outpatient clinic of the Teaching Hospital of the Federal University of Pelotas. Methods: Cross-sectional study in which patients were selected from a convenience sample. Patients treated at the outpatient clinic from January from 2018 to July 2019 were included. Data collection was performed through the review of medical records. Results: sixty-eight (68) patients were evaluated, 63% of whom were women, with an average age of 43 years. Fifty-six 56% of patients had Crohn's disease and 44% Ulcerative Rectocolitis. In Crohn's disease the most common involvement was ileocolonic (46%) and in Ulcerative Rectocolitis it was extensive colitis (56%). Crohn's disease patients were the ones who most hospitalized 64% and underwent surgical procedures 5.8 times more than Ulcerative Rectocolitis patients. An increased prevalence of psychiatric diseases was observed, affecting approximately one third of patients with Ulcerative Rectocolitis and around one fifth among patients with Crohn's Disease. In the treatment there was a predominance of the use of salicylates in Ulcerative Rectocolitis and immunosuppressants and immunobiologicals in Crohn's Disease. Conclusion: The profile of patients with inflammatory bowel diseases at the outpatient clinic of Federal University of Pelotas is similar to that found in the literature.


Crohn's disease; Ulcerative colitis; Inflammatory Bowel Diseases; outpatient clinic; patient profiles


- Ponte ACA, Damião AOMC, Rosa AM et al. Brazilian Study Group Of Inflammatory Bowel Diseases. Consensus Guidelines for the Management of Inflammatory Bowel Disease. Arq Gastroenterol. 2010;47(3):313 – 325.

- Bernstein C, Eliakim A, Fedail S et al. Doença inflamatória intestinal. World Gastroenterology Organisation. Practice Guidelines. 2015;1 – 38.

- Molodecky NA, Soon IS, Rabi DM et al. Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review. Gastroenterology. 2011;142 (1):46 – 54.

- Rubin DT, Ananthakrishnan AN, Ananthakrishnan AN. et al. ACG Clinical Guideline: Ulcerative Colitis in Adults. Am J of Gastroenterol. 2019;114 (3):384 – 384.

- Lichtenstein GR, Loftus EV, Isaacs KL. et al. ACG Clinical Guideline: Management of Crohn’s Disease in Adults. Am J of Gastroenterol. 2018;113 (4):481 – 517.

- dos Santos RM, Carvalho ATP, dos Santos Silva K. et al. Inflammatory bowel disease: outpatient treatment profile. Arq Gastroenterol. 2017;54(2):96 – 100.

- Kleinubing-Júnior H, de S L Pinho M, Ferreira LC. et al. Perfil dos pacientes ambulatoriais com doenças inflamatórias intestinais. Abcd Arq Brasil Cir Digest. 2011; 24(3):200 – 203.

- de Barros PAC, da Silva AMR, d F Lins Neto MA. The epidemiological profile of inflammatory bowel disease patients on biologic therapy at a public hospital in Alagoas. J of Colopro. 2014; 34 (3):131 – 135.

- de Souza MM, Belasco AGS, de Aguilar-Nascimento JE. Perfil epidemiológico dos pacientes portadores de doença inflamatória intestinal do estado de Mato Grosso. Rev Bras Coloproc. 2008;28(3):324 – 328.

- Bardhan KD, Simmonds N, Royston C. et al. A United Kingdom inflammatory bowel disease database: Making the effort worthwhile. J of Crohn’s and Colitis. 2010;4(4):405 – 412.

- Bechara CS, Lacerda Filho A, Ferrari MLA. et al. Montreal classification of patient operated for Crohn’s disease and identification of surgical recurrence predictors. Rev Col Bras Cir. 2015;42(2):97 – 104.

- Cleynen I, Boucher G, Jostins L. et al. Inherited determinants of Crohn’s disease and ulcerative colitis phenotypes: a genetic association study. The Lancet. 2016 ; 387(10014):156 – 167.

- Gomollón F, Dignass A, Annese V. et al. 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management. J of Crohn’s and Colitis. 2016;11(1):3 – 25.

- Harbord M, Eliakim R, Bettenworth D. et al. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management. J of Crohn’s and Colitis. 2017;11(7):769 – 784.

- Torres J, Mehandru S, Colombel J. et al. Crohn’s disease. The Lancet. 2017;389(10080):1741 – 1755.

- Forbes A, Escher J, Hebuterne X. et al. ESPEN guideline: Clinical nutrition in inflammatory bowel disease. Clin Nutrition. 2017;36(2):321 – 347.

- Lora FL, Amarante HMB, Pisani JC et al. Avaliação da densidade mineral óssea em pacientes com doença inflamatória intestinal. Arq Gastroenterol. 2005; 42(4):201 – 205.

- Lima FDVD, Ribeiro TCDR, Chebli LA. et al. Oscilação do humor em pacientes com doença de Crohn: incidência e fatores associados. Rev Med Bras. 2012;58(4):481 – 488.

- Andrews H, Barczak P, Allan RN. Psychiatric illness in patients with inflammatory bowel disease. Gut. 1987;28(12):1600 – 1604.

- Byrne G, Rosenfeld G, Leung Y. et al. Prevalence of Anxiety and Depression in Patients with Inflammatory Bowel Disease. Can J of Gastroenterol and Hepatol. 2017;2017:1 – 6.

- Martin-Subero M, Anderson G, Kanchanatawan B. et al. Comorbidity between depression and inflammatory bowel disease explained by immune-inflammatory, oxidative, and nitrosative stress; tryptophan catabolite; and gut– brain pathways. Cns Spectrums. 2015;21(2):184 – 198.

- Rahier JF, Magro F, Abreu C. et al. Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohn’s and Colitis. 2014;8(6):443 – 468.

- DATASUS. Internações hospitalares do SUS por local de internação>.

Full Text: PDF HTML


  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.